Home » Topics » Medical technology

Medical technology
RSS

Switching On Apaf-1, A Protein Inactivated In Tumors, To Revive Effectiveness Of Chemotherapy

Jan. 11, 2001

SciClone Begins Pivotal U.S. Trial Of Zadaxin In Hepatitis C Patients

Jan. 11, 2001

Millennium Delivering To Bayer 'First Genomics-Derived' Target

Jan. 11, 2001

Collateral, Berlex Plan Pivotal Angiogenic Gene Therapy Trial

Jan. 11, 2001

Other News To Note

Jan. 11, 2001

InterMune Buying Alza Drug For $9M, Boosting Sales Force

Jan. 10, 2001

Xantos Formed Around Platform To Perform Functional Genomics

Jan. 10, 2001

European Parliament Report Calls For Separation Of Biotech Areas

Jan. 10, 2001

By Peter O'Donnell

Adverse Events In Oxygent Patients Stops Alliance Study, Drops Stock

Jan. 10, 2001

IntraBiotics Paying Diversa $20M In Antibacterial Deal

Jan. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...